Where does Institut Quimic DE Sarria Cets Fundacio Privada rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Institut Quimic DE Sarria Cets Fundacio Privada ranks #47,754 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Institut Quimic DE Sarria Cets Fundacio Privada hold?

Institut Quimic DE Sarria Cets Fundacio Privada holds 5 US utility patents granted between 2016 and 2024, spanning 12 technology areas.

What is Institut Quimic DE Sarria Cets Fundacio Privada's Innovation Score?

Institut Quimic DE Sarria Cets Fundacio Privada has an Innovation Score of 35.1 out of 100 (top 50% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Institut Quimic DE Sarria Cets Fundacio Privada's patent grant rate increasing or decreasing?

Institut Quimic DE Sarria Cets Fundacio Privada's recent grant velocity is -75% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Institut Quimic DE Sarria Cets Fundacio Privada's patents?

Institut Quimic DE Sarria Cets Fundacio Privada's patents average 16.6 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Institut Quimic DE Sarria Cets Fundacio Privada

Q: What technology areas does Institut Quimic DE Sarria Cets Fundacio Privada focus on?

Institut Quimic DE Sarria Cets Fundacio Privada's top technology area is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations) with 3 patents. Grants appear in 12 CPC subclasses total.

Q: How is the Institut Quimic DE Sarria Cets Fundacio Privada patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO PatentsView assignee record - 5 granted patents across 12 technology areas, recorded in grant years 2016–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Institut ranks #47,754 of 49,997 tracked US assignees by granted-patent volume, with 5 patents across 12 technology areas.

#47,754
of 49,997 US assignees by volume: Top 50%
by Innovation Score (35.1/100): 16.6
avg claims per patent: -75%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R47754 · Foreign Corporation #47,754 · 5 grants

GRANTS-MICRO · BOTTOM-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

GRANTS-MICRO 5 grants
BOTTOM-DECILE #47,754/49,997
PHOTO-FINISH Institut DE…
CPC-FOCUS A61P · 12 areas
INNOV-THIN 35.1/100
CLAIMS-RICH 16.6 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DROP -75% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Institut DE Cancerologie DE L'ouest (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Institut Quimic DE… · this assignee

35
3D Lighting… · lowest

7

What this shows Institut's Innovation Score is 35.1/100 (top 50% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Institut's grants concentrate

Institut Quimic DE Sarria Cets Fundacio Privada is a focused PatentsView assignee: 12 CPC subclasses with 60% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). By volume, Institut sits between Institut DE Cancerologie DE L'ouest and Institute OF Software, Chinese Academy OF Sciences.

Institut's three-year grant acceleration

Institut Quimic DE Sarria Cets Fundacio Privada shows 1 grants in 2022–2024 against only 1 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Institut DE Cance…

5
Institut DE Cardi…

5
Institut DE Recer…

5
Institut Pasteur…

5
Institut Telecom-…

5
Institute OF Info…

5
Institute OF Mech…

5
Institute OF Soft…

5
Institut Quimic D… ◀

5

What this shows Institut holds 5 patents at rank #47,672, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Institut

By rank, the assignees closest to #47,672 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Institut's primary technology class.

Institut's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

35 Top 50% higher than 50% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

Institut Quimic DE Sarria Cets Fundacio Privada patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	1	20.0%
2017	1	20.0%
2018	1	20.0%
2019	1	20.0%
2024	1	20.0%

Which technologies does Institut Quimic DE Sarria Cets Fundacio Privada patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 3

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 3

C07D - Heterocyclic Compounds 2

A61L - Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles 2

C09J - ADHESIVES; Non-mechanical Aspects OF Adhesive Processes IN GENERAL; Adhesive Processes NOT Provided FOR ELSEWHERE; USE OF Materials AS Adhesives 1

C08K - Use of inorganic or non-macromolecular organic substances as compounding ingredients 1

A01N - Preservation OF Bodies OF Humans OR Animals OR Plants OR Parts Thereof ; Biocides, e.g. AS Disinfectants, AS Pesticides OR AS Herbicides ; Pest Repellants OR ATTRACTANTS; Plant Growth Regulators 1

A23V - Indexing Scheme Relating TO Foods, Foodstuffs OR Non-alcoholic Beverages AND Lactic OR Propionic Acid Bacteria Used IN Foodstuffs OR Food Preparation 1

A23G - COCOA; Cocoa Products, e.g. CHOCOLATE; Substitutes FOR Cocoa OR Cocoa PRODUCTS; CONFECTIONERY; Chewing GUM; ICE-CREAM; Preparation Thereof 1

A23L - Foods, Foodstuffs OR Non-alcoholic Beverages, NOT Otherwise Provided FOR; Preparation OR Treatment Thereof 1

A23C - Dairy Products, e.g. Milk, Butter OR CHEESE; Milk OR Cheese SUBSTITUTES; Making OR Treatment Thereof 1

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 1

Top 12 of 12 technology areas

Where it ranks

Overall rank by patents

#47,754

of 49,997 tracked assignees

Innovation Score

35.1 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Institut Quimic DE Sarria Cets Fundacio Privada's patent record in context - here's where to go next.

Institut Quimic DE Sarria Cets Fundacio Privada's lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 60% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #47,754 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Institut Quimic DE Sarria Cets Fundacio Privada against Institut DE Cancerologie DE L'ouest, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 35.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.